R&D

Philips spends big in-house while Becton favours buying
EP Vantage
Wed, 08/5/20 - 11:08 pm
devices
R&D
Philips
Becton Dickinson
Pfizer reups PPD deal in a contract research pact spree
Fierce Biotech
Wed, 08/5/20 - 09:39 am
Pfizer
R&D
CROs
PPD
Philips spends big in-house while Becton favours buying
EP Vantage
Fri, 07/31/20 - 10:52 am
devices
Philips
Becton
R&D
Lexicon bids farewell to top seller Xermelo in reorganization toward R&D pipeline
Endpoints
Thu, 07/30/20 - 11:03 am
Lexicon Pharmaceuticals
Xermelo
R&D
TerSera Therapeutics
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
Wed, 07/29/20 - 12:41 pm
GSK
R&D
COPD
HIV
cancer
Merck taps contract research firm IRBM for peptides to hit back at pandemic virus
Fierce Biotech
Tue, 07/21/20 - 04:55 pm
Merck
IRBM
COVID-19
R&D
peptides
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
R&D
drug development
Eli Lilly
Novartis
Argenx
Bristol-Myers Squibb
Vir Biotechnolgy
Biogen
GSK
Iovance
Roche
After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure
Endpoints
Mon, 07/13/20 - 11:09 am
Merck
Dewpoint Therapeutics
HIV
R&D
Out to revive R&D, a resurgent Sanofi pays $150M cash to partner up with a pioneering protein degradation player
Endpoints
Thu, 07/9/20 - 10:57 am
Sanofi
protein degradation
immunology
R&D
Kymera
Biotech Gilead axes $445M Precision Biosciences gene therapy hep B pact
Fierce Biotech
Wed, 07/8/20 - 10:39 am
Gilead Sciences
Precision Biosciences
hepatitis B
R&D
Boehringer creates Shanghai hub to connect with Chinese R&D groups
Fierce Biotech
Mon, 07/6/20 - 10:30 am
Boehringer Ingelheim
China
Shanghai
R&D
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Fierce Biotech
Tue, 06/30/20 - 10:35 am
Mereo BioPharma
IPOs
OncoMed
R&D
Sanofi Streamlines Pipeline Focus While Looking Ahead to a Post-COVID-19 World
BioSpace
Sat, 06/27/20 - 11:39 pm
Sanofi
R&D
COVID-19
pandemic
Sangamo R&D chief hits the exit as it splits R&D into separate units
Fierce Biotech
Thu, 06/25/20 - 10:35 am
Sangamo
R&D
Pfizer
hemophilia
Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work
Endpoints
Thu, 06/25/20 - 10:32 am
Takeda
Enterome
microbiome
R&D
Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases
BioSpace
Wed, 06/24/20 - 10:28 am
Yumanity Therapeutics
Merck
ALS
frontotemporal lobar dementia
R&D
A virtual biotech incubator is launching with the help of Evotec and Samsara, looking for a few good scientists in need of seed cash for spinouts
Endpoints
Wed, 06/24/20 - 10:15 am
R&D
biotech
incubators
Evotec
Samsara
Autobahn Labs
Sanofi's fight for a better research reputation
BioPharma Dive
Tue, 06/23/20 - 11:34 pm
Sanofi
R&D
cancer
immune disorders
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
Fierce Biotech
Tue, 06/16/20 - 10:56 am
GSK
cancer
R&D
oncology
Ideaya
genome editing
Large R&D Investments By Big Pharma Crucial In Fighting Covid-19, But Can It Last?
Forbes
Tue, 06/16/20 - 10:39 am
R&D
COVID-19
pandemic
drug discovery
drug development

Pages